Penumbra Catheter Recall Issued for Neuron 6F 070 Delivery Catheter

|

Older versions of Penumbra Inc.’s Neuron 6F 070 Delivery Catheter have been recalled in the wake of reports that some catheters have kinked, ovalized or broken, resulting in injuries.

The Penumbra Neuron delivery catheter recall was announced September 29 and affects 31 lots of the original versions of the catheters. If the catheters kink or collapse when bent, it could result in waste not being removed from the patient, potentially resulting in life-threatening complications.

A kinked or ovalized catheter can restrict the flow of material through the catheter, cause problems with the insertion of other devices through the guide catheter, and can lead to the catheter breaking after continued use.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Only the original versions of the Neuron 6f 070 Delivery Catheters are being recalled. The recall affects products with the catalog numbers PND6F0701058, PND6F0701058M, PND6F070956 and PND6F070956M, and with the lot numbers F13733, F13751, F13773, F13799, F13817, F13826, F13856, F13865, F13880, F13899, F13934, F13960, F13970, F13971, F13980, F13997, F14007, F14028, F14045, F14046, F14047, F14048, F14102, F14103, F14150, F14182, F14183, F14427, F14482, F14560 and F14629.

The recall does not affect catheters with lot numbers F14630 or higher.

Anyone using a recalled Neuron 6F 070 Delivery Catheter should stop using the device and return it for a replacement. Penumbra has notified hospitals who bought the devices through the use of notification letters.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.
A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkin’s lymphoma.
Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.